Stay updated on TACTIVE-U Study of ARV-471 Combo in Adv Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the TACTIVE-U Study of ARV-471 Combo in Adv Breast Cancer Clinical Trial page.

Latest updates to the TACTIVE-U Study of ARV-471 Combo in Adv Breast Cancer Clinical Trial page
- Check6 days agoChange DetectedThe ClinicalTrials.gov record is now available with study details, eligibility criteria, locations, and outcome measures. It states that the study was terminated after enrolling 20 participants and is no longer recruiting.SummaryDifference63%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedA banner announces an NIH website transition and says federal agencies are using “Super Intelligence” in place of “Artificial Intelligence.” The clinical trial record remains inaccessible behind a 403 error.SummaryDifference1%

- Check34 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2 while the page remained a 403 error.SummaryDifference0.2%

- Check41 days agoChange DetectedThe ClinicalTrials.gov page remains a 403 error, with the footer revision updated from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check48 days agoChange DetectedThe study page currently shows a 403 Forbidden error, indicating access is blocked for this URL rather than an update to the study's details. The site chrome remains, but the content is not retrievable.SummaryDifference0.5%

- Check55 days agoChange DetectedThe study page now renders as a 403 Forbidden error page, showing the site header and footer but no study content, replacing the usual study details and related information.SummaryDifference18%

Stay in the know with updates to TACTIVE-U Study of ARV-471 Combo in Adv Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TACTIVE-U Study of ARV-471 Combo in Adv Breast Cancer Clinical Trial page.